
08/25/2025
🧪 Cannabis Delivery Innovation in Europe
As research into cannabis compounds and healthy aging gains momentum, European healthcare providers are investigating how SubMagna® HMW could be useful in compounded sublingual cannabinoid administration.
Why it matters: SubMagna® HMW's unique absorption profile could offer precision dosing, enhanced bioavailability, and non-invasive delivery for therapeutic cannabis applications.
📍 From pain management to neuroprotection, this could reshape how we think about formulation strategy and patient access.
Compounded medications are not reviewed by FDA for safety or efficacy.
Cannabis compounds are showing early promise for healthy aging, a new study has found. However, much more research is needed to learn how results might differ depending on the frequency of use and the individual. Researchers in the UK reviewed 18 different studies across 15 years of research (2008 t...